Exchange: NASDAQ·Updated 02:02 PM EDT
News
all
press releases
Indivior Pharmaceuticals Inc. (INDV) Q2 Earnings and Revenues Beat Estimates
Indivior Pharmaceuticals Inc. (INDV) delivered earnings and revenue surprises of +18.56% and +11.36%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
Will Ardelyx (ARDX) Report Negative Earnings Next Week? What You Should Know
Ardelyx (ARDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
New Strong Sell Stocks for July 29th
ARDX, BDORY and AXSM have been added to the Zacks Rank #5 (Strong Sell) List on July 29, 2026.
Zacks
New Strong Sell Stocks for July 23rd
ABR, ARDX and RGNX have been added to the Zacks Rank #5 (Strong Sell) List on July 23, 2026.
Zacks
ARDX Stock Tumbles As Xphozah Loses Final Medicare Reimbursement Battle
The U.S. Court of Appeals for the D.C. Circuit said federal law prevents judges from reviewing Medicare’s decision to include certain kidney drugs in the dialysis payment bundle.
Stocktwits
Aquestive Therapeutics (AQST) Moves 6.6% Higher: Will This Strength Last?
Aquestive Therapeutics (AQST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
Ardelyx Stock Up 70%: What to Know About This $490,000 Insider Transaction
Key PointsAccording to an SEC filing, an executive at Ardelyx reported selling 81,898 directly held Common Stock shares on June 18, 2026, generating a transaction value of $490,000...
Nasdaq News: Markets
ARDX Edges Up After Hours On IBSRELA Momentum And Profitability ‘Right Around The Corner’
CFO said at a conference that profitability is “right around the corner,” though the company is waiting for more top-line certainty before formal guidance.
Stocktwits
Should You Buy Ardelyx (ARDX)?
Should You Buy Ardelyx (ARDX...
Yahoo! Finance: News
Ardelyx (NASDAQ:ARDX) Trading Up 7.4% - What's Next?
Ardelyx (NASDAQ:ARDX) Shares Up 7.4% - What's Next...
MarketBeat

Advertisement|Remove ads.